Skip to Main Content

Author Details

Ivet Bahar
Laufer Center for Physical and Quantitative Biology, Stony Brook University
1994
275
70
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37732203Structural mechanisms for VMAT2 inhibition by tetrabenazine.bioRxiv2024
36630507Syntaxin 1 Ser<sup>14</sup> phosphorylation is required for nonvesicular dopamine release.Sci Adv2023
38014259Influence of Point Mutations on PR65 Conformational Adaptability: Insights from Nanoaperture Optical Tweezer Experiments and Molecular Simulations.Res Sq2023
37996701Anomalous peroxidase activity of cytochrome c is the primary pathogenic target in Barth syndrome.Nat Metab2023
38055679Structural basis of G protein-Coupled receptor CMKLR1 activation and signaling induced by a chemerin-derived agonist.PLoS Biol2023
37678654Membrane regulation of 15LOX-1/PEBP1 complex prompts the generation of ferroptotic signals, oxygenated PEs.Free Radic Biol Med2023
36948205Cooperative mechanics of PR65 scaffold underlies the allosteric regulation of the phosphatase PP2A.Structure2023
37245287Formation of protein adducts with Hydroperoxy-PE electrophilic cleavage products during ferroptosis.Redox Biol2023
37176156Structural Dynamics Predominantly Determine the Adaptability of Proteins to Amino Acid Deletions.Int J Mol Sci2023
37333145Structural basis of CMKLR1 signaling induced by chemerin9.bioRxiv2023
37327313Discovering selective antiferroptotic inhibitors of the 15LOX/PEBP1 complex noninterfering with biosynthesis of lipid mediators.Proc Natl Acad Sci U S A2023
36587424Mutually beneficial confluence of structure-based modeling of protein dynamics and machine learning methods.Curr Opin Struct Biol2023
36503956Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications.Endocr Rev2023
35194576Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions.iScience2022
35736460A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies.Metabolites2022
35728652Activation and Speciation Mechanisms in Class A GPCRs.J Mol Biol2022
35639793Elastic network modeling of cellular networks unveils sensor and effector genes that control information flow.PLoS Comput Biol2022
35362464Protein dynamics developments for the large scale and cryoEM: case study of ProDy 2.0.Acta Crystallogr D Struct Biol2022
35858570GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation.Cell Rep2022
35875685Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains.iScience2022
36001481Structural and Dynamic Effects of PTEN C-Terminal Tail Phosphorylation.J Chem Inf Model2022
35984707Discovery of (<i>R</i>)-<i>N</i>-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [<b>(<i>R</i>)-AS-1</b>], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity <i>In Vivo</i>.J Med Chem2022
35101798Inactivation of RIP3 kinase sensitizes to 15LOX/PEBP1-mediated ferroptotic death.Redox Biol2022
34949836Precise druggability of the PTH type 1 receptor.Nat Chem Biol2022
35187088Sampling of Protein Conformational Space Using Hybrid Simulations: A Critical Assessment of Recent Methods.Front Mol Biosci2022
35308796Editorial: Targeting Membrane Proteins: Structure-Function-Dynamics Relationships.Front Chem2022
34906999Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in <i>Caenorhabditis elegans</i> through Interactions with the Dopamine Transporter DAT-1.Mol Pharmacol2022
34895471Llamanade: An open-source computational pipeline for robust nanobody humanization.Structure2022
35194603Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains.bioRxiv2022
32866476State-dependent sequential allostery exhibited by chaperonin TRiC/CCT revealed by network analysis of Cryo-EM maps.Prog Biophys Mol Biol2021
33547253Harold A. Scheraga (10/18/1921-8/1/2020): A pioneering scientist who laid the foundations of protein science in the 20th century.Proc Natl Acad Sci U S A2021
33546598Coupled mixed model for joint genetic analysis of complex disorders with two independently collected data sets.BMC Bioinformatics2021
33542532Phospholipase iPLA<sub>2</sub>β averts ferroptosis by eliminating a redox lipid death signal.Nat Chem Biol2021
33822884ProDy 2.0: increased scale and scope after 10 years of protein dynamics modelling with Python.Bioinformatics2021
33705359HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.J Clin Invest2021
33610553Direct coupling of oligomerization and oligomerization-driven endocytosis of the dopamine transporter to its conformational mechanics and activity.J Biol Chem2021
33930306A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro.Structure2021
33831302Predicting Protein-Protein Interactions Using Symmetric Logistic Matrix Factorization.J Chem Inf Model2021
34957043Bile Acids Gate Dopamine Transporter Mediated Currents.Front Chem2021
34609896Spatial bias in cAMP generation determines biological responses to PTH type 1 receptor activation.Sci Signal2021
34804551Approximating deformation fields for the analysis of continuous heterogeneity of biological macromolecules by 3D Zernike polynomials.IUCrJ2021
34067535NO<sup>⿏</sup> Represses the Oxygenation of Arachidonoyl PE by 15LOX/PEBP1: Mechanism and Role in Ferroptosis.Int J Mol Sci2021
34240914Normal mode analysis of membrane protein dynamics using the vibrational subsystem analysis.J Chem Phys2021
34240100ClustENMD: efficient sampling of biomolecular conformational space at atomic resolution.Bioinformatics2021
34339582A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.Mol Syst Biol2021
34199621Functional Characterization of the Dopaminergic Psychostimulant Sydnocarb as an Allosteric Modulator of the Human Dopamine Transporter.Biomedicines2021
34002696Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia.Elife2021
34373858<i>Llamanade</i> : an open-source computational pipeline for robust nanobody humanization.bioRxiv2021
31796894A network of phosphatidylinositol (4,5)-bisphosphate (PIP<sub>2</sub>) binding sites on the dopamine transporter regulates amphetamine behavior in Drosophila Melanogaster.Mol Psychiatry2021
33053463Adaptability and specificity: how do proteins balance opposing needs to achieve function?Curr Opin Struct Biol2021
  • 1 - 50 of 275

Recommended Authors

Neil J Bruce
Heidelberg Institute for Theoretical Studies (HITS)
Career Start Year 2010
Number of shared co-authors 1
Ignacia Echeverria
University of California san francisco
Career Start Year 2010
Number of shared co-authors 1
Massimiliano Bonomi
Institut Pasteur, Universite Paris Cite, CNRS UMR 8
Career Start Year 2007
Number of shared co-authors 1
Barak Raveh
The Hebrew University of Jerusalem
Career Start Year 2007
Number of shared co-authors 2
James S Fraser
University of California san francisco
Career Start Year 2006
Number of shared co-authors 7
Amitava Roy
University of Montana
Career Start Year 2006
Number of shared co-authors 1
Abhishek K Jha
Elucidata Corporation
Career Start Year 2005
Number of shared co-authors 2
Riccardo Pellarin
CNRS UMR 5086 and Universite Claude Bernard Lyon 1
Career Start Year 2003
Number of shared co-authors 1
Henry van den Bedem
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 0
Rommie E Amaro
University of California
Career Start Year 2001
Number of shared co-authors 2
Manuel Rueda
The Barcelona Institute of Science and Technology
Career Start Year 2001
Number of shared co-authors 1
Matteo Dal Peraro
Institute of Bioengineering
Career Start Year 2001
Number of shared co-authors 2
David E Shaw
Columbia University
Career Start Year 2000
Number of shared co-authors 5
Matthew P Jacobson
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 2
Michael Feig
Michigan State University
Career Start Year 1998
Number of shared co-authors 1
Marc F Lensink
University Lille, CNRS
Career Start Year 1996
Number of shared co-authors 1
Michele Vendruscolo
University of Cambridge
Career Start Year 1996
Number of shared co-authors 7
Gerhard Hummer
Max Planck Institute of Biophysics
Career Start Year 1994
Number of shared co-authors 3
Huan-Xiang Zhou
University of Illinois Chicago
Career Start Year 1993
Number of shared co-authors 4
Giorgio Colombo
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1993
Number of shared co-authors 0
Alexandre M J J Bonvin
Bijvoet Center for Biomolecular Research, Utrecht University
Career Start Year 1991
Number of shared co-authors 10
Paul A Bates
The Francis Crick Institute
Career Start Year 1989
Number of shared co-authors 2
Rebecca C Wade
Center for Molecular Biology (ZMBH), Heidelberg University
Career Start Year 1989
Number of shared co-authors 1
Michael Nilges
Institut Pasteur
Career Start Year 1986
Number of shared co-authors 3
Ariel Fern??ndez
University of Florida
Career Start Year 1984
Number of shared co-authors 1
Ruth Nussinov
Sackler School of Medicine, Tel Aviv University
Career Start Year 1980
Number of shared co-authors 4
David A Case
Rutgers University
Career Start Year 1977
Number of shared co-authors 6
Charles L Brooks
University of Michigan ann arbor
Career Start Year 1974
Number of shared co-authors 3
Michael Levitt
Stanford University
Career Start Year 1969
Number of shared co-authors 2
Martin Karplus
Harvard University
Career Start Year 1959
Number of shared co-authors 4

Collaborators

Valerian E Kagan
Center for Free Radical and Antioxidant Health, University of Pittsburgh
Co-authored papers 22
She Zhang
University of Pittsburgh School of Medicine
Co-authored papers 16
Simon C Watkins
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Co-authored papers 9
Timothy R Lezon
University of Pittsburgh
Co-authored papers 8
Andrew P VanDemark
University of Pittsburgh
Co-authored papers 7
Zolt??n N Oltvai
University of Rochester
Co-authored papers 7
Judith Klein-Seetharaman
School of Molecular Sciences & College of Health Solutions, Arizona State University
Co-authored papers 6
George Ermentrout
University of Pittsburgh
Co-authored papers 4
Turkan Haliloglu
Co-authored papers 4
Jose Maria Carazo
National Centre for Biotechnology (CNB CSIC), Campus Universidad Autonoma de Madrid
Co-authored papers 4
Angela M Gronenborn
University of Pittsburgh
Co-authored papers 4
Zheng Yang
and Clinical & Translational Science Institute, University of Pittsburgh
Co-authored papers 4
Gary A Silverman
Washington University School of Medicine
Co-authored papers 4
Timothy R Billiar
University of Pittsburgh
Co-authored papers 3
Yoram Vodovotz
University of Pittsburgh
Co-authored papers 3
Yi Shi
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Massimo Cristofanilli
Weill Cornell School of Medicine
Co-authored papers 3
David C Whitcomb
University of Pittsburgh Medical Center
Co-authored papers 3
Xinghua Lu
Co-authored papers 3
Fan Zheng
University of California San Diego
Co-authored papers 2
Ralph S Baric
University of North Carolina
Co-authored papers 2
Dimiter S Dimitrov
Co-authored papers 2
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 2
Christopher Churas (CM4AI)
University of California San Diego
Co-authored papers 2
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers 2
Brent R Stockwell
Columbia University
Co-authored papers 2
Hyun Woo Park
College of Life Science and Biotechnology, Yonsei University
Co-authored papers 2
Dexter Pratt (CM4AI)
UC San Diego
Co-authored papers 2
Kunhong Xiao
Co-authored papers 2
Jeremy Berg
Co-authored papers 2
Release 1.2